Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. 1998

A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
Department of Diagnostic Imaging, University of Naples Federico II, Nuclear Medicine Center of the National Research Council, Italy.

Thallium-201 is clinically used for the assessment of primary and recurrent brain tumors. The biologic properties of 201Tl that allow it to accumulate within the tumor cells render 201Tl useful in evaluating tumor malignancy, but its physical characteristics and nonroutine availability limits its use in some institutions, as compared to 99mTc-labeled compounds. The aim of this study was to assess the feasibility of using 99mTc-tetrofosmin for imaging brain tumors and to compare its uptake with that of 201Tl. METHODS Twenty-six patients with 27 intracranial masses were studied with SPECT. In the first group of seven patients (Group A), the timing for optimal acquisition of the 99mTc-tetrofosmin scan was assessed. In the second group of 19 patients (Group B), two sequential 201Tl (74-148 MBq intravenous) and 99mTc-tetrofosmin (740-925 MBq intravenous) studies were performed 20 min after tracer injection and compared. RESULTS In Group A, no significant difference in the tumor-to-background (T/B) ratio among the 20-, 40- and 120-min postinjection studies was observed. In Group B, the quality of reconstructed images with 99mTc-tetrofosmin, judged visually, was superior to that of 201Tl in 47% of all studies and was comparable in the remaining 53%. A significant relationship between 201Tl and 99mTc-tetrofosmin T/B ratio (r = 0.75, p < 0.01) was found. The T/B ratio of 99mTc-tetrofosmin was significantly higher than that of 201Tl (23.3 +/- 21.5 compared to 6.1 +/- 2.9, p < 0.005). CONCLUSIONS Technetium-99m-tetrofosmin is a suitable radiotracer for the imaging of intracranial lesions with SPECT. Moreover, a better definition of tumor margins and a higher contrast between neoplastic and normal brain tissue can be achieved.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013793 Thallium A heavy, bluish white metal, atomic number 81, atomic weight [204.382; 204.385], symbol Tl. Thallium-205,Thallium 205

Related Publications

A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
February 1996, Annals of nuclear medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
April 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
February 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
September 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
November 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
December 1996, European journal of nuclear medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
January 1995, Acta neurologica Scandinavica,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
November 1993, The American journal of cardiology,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
August 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Soricelli, and A Cuocolo, and A Varrone, and A Discepolo, and E Tedeschi, and P P Mainenti, and M R Grivet-Fojaja, and E M Covelli, and A Postiglione, and M Salvatore
July 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!